Clinical oncology is defined by continual discovery. New trials, biomarkers, and therapeutic advances continue to reshape best practices, making timely access to the latest evidence essential.
Today, we’re thrilled to announce a new agreement with the American Society of Clinical Oncology (ASCO®) that will bring ASCO Guidelines into DoxGPT, Doximity’s evidence-backed, HIPAA-compliant medical AI for clinicians.
DoxGPT, powered by PeerCheck™, combines AI automation with physician verification, reinforcing the foundational role that peer review and expert consensus play in evidence-based medicine. ASCO Guidelines include evidence-based recommendations and outline appropriate methods of treatment and care for clinicians.
ASCO is a leading professional organization for physicians and oncology professionals caring for people with cancer. Its guidelines offer timely, trustworthy information to help clinicians make evidence-based decisions.
ASCO Guidelines include both standard and “living guidelines,” which are specifically designed for areas of oncology where evidence is evolving rapidly. Standing expert panels conduct systematic reviews of health literature and update living guidelines on a regular schedule.
Bringing ASCO’s comprehensive guidelines into DoxGPT is part of Doximity’s broader strategy to deliver clinical AI that physicians can trust. AI technology is quickly becoming a commodity, but medical trust is not. Clinicians want answers that are AI-fast and textbook-trusted.
With the introduction of ASCO Guidelines, DoxGPT users can access current oncology standards with accuracy and confidence, as every ASCO guideline is reviewed by a multidisciplinary expert panel.